Viatris Inc.: Pulmonary Arterial Hypertension trials

The registry lists 17 Pulmonary Arterial Hypertension studies with Viatris Inc. as lead sponsor. 0 are open to participants now and 9 have results posted.

Phase 3 5Phase 4 4No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Effects of Oral Sildenafil on Mortality in Adults With PAHTerminatedNCT02060487Phase 4Results posted
• Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial HypertensionCompletedNCT01642407Phase 4Results posted
• Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial HypertensionCompletedNCT01365585Results posted
• To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 WeeksCompletedNCT00946114Results posted
• Open Label Study of Sildenafil in Patients With Pulmonary Arterial HypertensionCompletedNCT00454207Phase 3Results posted
• To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension.TerminatedNCT00430716Phase 4Results posted
• Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00323297Phase 4Results posted
• A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.CompletedNCT00159913Phase 3Results posted
• A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In ChildrenCompletedNCT00159874Phase 3Results posted
• Revatio Special Investigation for Long-term Use in Pediatric PatientsCompletedNCT03364244
• Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With SildenafilNo longer availableNCT01897740
• Patient Reported Outcomes in Pulmonary Arterial HypertensionWithdrawnNCT01792622
• An Open Label Access Study For Subjects Who Completed A1481156No longer availableNCT01582438
• Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 StudyNo longer availableNCT00878943
• Local Open-Label Access Study For Patients Who Completed A1481244 Study In BrazilNo longer availableNCT00866983
• A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial HypertensionCompletedNCT00644605Phase 3
• Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial HypertensionCompletedNCT00159887Phase 3